Drug Shortage Report for TARO-TEMOZOLOMIDE
Report ID | 109188 |
Drug Identification Number | 02443511 |
Brand name | TARO-TEMOZOLOMIDE |
Common or Proper name | TEMOZOLOMIDE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TEMOZOLOMIDE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 5 blister |
ATC code | L01AX |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-20 |
Estimated end date | 2020-06-12 |
Actual end date | 2020-06-12 |
Shortage status | Resolved |
Updated date | 2020-06-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-03-20 | English | Compare |
v2 | 2020-03-20 | French | Compare |
v3 | 2020-03-21 | English | Compare |
v4 | 2020-03-30 | English | Compare |
v5 | 2020-03-30 | French | Compare |
v6 | 2020-05-01 | English | Compare |
v7 | 2020-05-01 | French | Compare |
v8 | 2020-06-23 | English | Compare |
v9 | 2020-06-23 | French | Compare |
Showing 1 to 9 of 9